Back to top

NIH Funding Opportunities

Updated June 23 2017
Online Partnership to Accelerate Research (OnPAR)

Leidos has worked with NIH Program Officers to inform applicant Principal Investigators that have scored well, but below the Institue/Center payline, about OnPAR. If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process described below. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement.

For more information, click here.
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24)
(PAR-15-266)
National Cancer Institute
Application Receipt/Submission Dates: November 17, 2017, June 14, 2018, by 5:00 PM local time of applicant organization. 
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)
(PAR-15-334
National Cancer Institute
Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization
Sustained Support for Informatics Resources for Cancer Research and Management (U24)
(PAR-15-333
National Cancer Institute
Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
(PAR-15-332
National Cancer Institute
Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization
Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
(PAR-15-331
National Cancer Institute
Application Receipt/Submission Dates: November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.
Single-Site Investigator-Initiated Clinical Trials (R61/R33)
(PAR-16-405)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 11, 2017; February 13, 2018; June 14, 2018; October 11, 2018; February 13, 2019; June 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
(RFA-MH-17-614)
National Institute of Mental Health
Application Receipt Dates: October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34)
(RFA-MH-17-612)
National Institute of Mental Health
Application Receipt Dates: October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01)
(RFA-MH-17-610)
National Institute of Mental Health
Application Receipt Dates: October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01)
(RFA-MH-17-608)
National Institute of Mental Health
Application Receipt Dates: June 14, 2017; October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
(RFA-MH-17-606)
National Institute of Mental Health
Application Receipt Dates: June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33)
(RFA-MH-17-604)
National Institute of Mental Health
Application Receipt Dates: June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)

(PA-17-248)
National Cancer Institute
Application Receipt/Submission Date: June 15, 2017 by 5:00 PM local time of applicant organization

Cancer-related Behavioral Research through Integrating Existing Data (R21)
(PAR-16-255)
National Cancer Institute
Application Receipt/Submission Dates: June 15, 2017; February 15, 2018; June 15 2018; February 15, 2019; June 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01)
(PAR-15-314)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: June 15, 2017; June 15, 2018 , by 5:00 PM local time of applicant organization. 
Paul Calabresi Career Development Award for Clinical Oncology (K12)
(PAR-16-189)
National Cancer Institute
Application Receipt/Submission Dates: June 15, 2017; June 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Novel Nucleic Acid Sequencing Technology Development (R21)
(RFA-HG-15-031)
National Human Genome Research Institute
Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization. 
Novel Nucleic Acid Sequencing Technology Development (R01)
(RFA-HG-15-032)
National Human Genome Research Institute
Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization. 
Novel Nucleic Acid Sequencing Technology Development (R43/R44)
(RFA-HG-15-033)
National Human Genome Research Institute
Application Receipt Dates: June 15, 2017, by 5:00 PM local time of applicant organization.
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
(RFA-MH-17-600)
National Institute of Mental Health
Application Receipt Dates: June 15, 2017; October 15, 2017, February 15, 2018, June 15, 2018, October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03)
(RFA-HL-16-020)
National Heart, Lung, and Blood Institute
Application Receipt Dates: June 15, 2017; October 19, 2017; February 15, 2018; June 15, 2018, by 5:00 PM local time of applicant organization. 
Developing Interventions for Health-Enhancing Physical Activity (R21/R33)
(PAR-14-321)
Office of Disease Prevention
National Center for Complementary and Alternative Medicine
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Office of Behavioral and Social Science Research
Office of Research on Women's Health
For new applications: June 16, 2017
For resubmission application: July 16, 2017 
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)
(RFA-HL-16-009)
National Heart, Lung, and Blood Institute
Application Receipt Date: June 19, 2017, by 5:00 PM local time of applicant organization.
NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34)
(PAR-15-068)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Due Date: June 19, 2017
AIDS Application Due Date: September 7, 2017 
Basic Cancer Research in Cancer Health Disparities (R01)
(PAR-15-093)
National Cancer Institute
Application Receipt/Submission Dates: June 19, 2017; November 17, 2017, by 5:00 PM local time of applicant organization. 
Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)
(PAR-15-092)
National Cancer Institute
Application Receipt/Submission Dates: June 19, 2017; November 17, 2017, by 5:00 PM local time of applicant organization. 
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01)
(PAR-16-320)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Dates: June 19, 2017; October 17, 2017; February 15, 2018; June 19, 2018; October 19, 2018; February 15, 2019; and June 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)

(RFA-DE-18-004)
National Institute of Dental and Craniofacial Research
Application Receipt Date: June 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24)

(PAR-17-228)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 19, 2017, October 23, 2017, June 19, 2018, October 23, 2018, June 19, 2019, October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Genomics and Informatics Center for the SubPopulations and InteRmediate Outcomes Measures In COPD Study (SPIROMICS) (U24) 

(RFA-HL-18-011)
National Heart, Lung, and Blood Institute
Application Receipt Date: June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)

(RFA-MH-18-200)
National Institute of Mental Health
Application Receipt Dates: June 20, 2017, June 20, 2018, June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) 

(RFA-DA-18-005)
National Institute on Drug Abuse
Application Receipt Date: June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01)
(PAR-15-279)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: June 21, 2017; October 20, 2017; and June 21, 2018, by 5:00 PM local time of applicant organization.
Image-guided Drug Delivery (R01)
(PAR-16-044)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: June 21, 2017; November 22, 2017; June 21, 2018; November 22, 2018, by 5:00 PM local time of applicant organization. 
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33)
(RFA-NS-16-013)
National Institute of Neurological Disorders and Stroke
National Institute on Drug Abuse
Application Receipt Dates: June 21, 2017; October 18, 2017 , by 5:00 PM local time of applicant organization.

Limited Competition: National Swine Resource and Research Center (U42)

(PAR-17-255)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Dates: June 21, 2017, September 25, 2017 and January 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Integrating Biospecimen Science into Clinical Assay Development (U01)
(PAR-16-166)
National Cancer Institute
Application Receipt/Submission Date: June 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)
(PAR-15-053)
National Cancer Institute
Application Receipt/Submission Dates: June 22, 2017; November 30, 2017 
Emerging Questions in Cancer Systems Biology (U01)
(PAR-16-131)
National Cancer Institute
Application Receipt/Submission Dates: June 23, 2017; November 24, 2017; June 22, 2018; November 23, 2018, by 5:00 PM local time of applicant organization
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3)
(PAR-16-065)
National Institute of Mental Health
Application Receipt/Submission Dates: June 23, 2017, October 24, 2017, February 23, 2018, June 26, 2018, October 24, 2018, by 5:00 PM local time of applicant organization

National Cooperative Drug/Device Discovery/Development Groups (U01) 

(PAR-17-185)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt/Submission Dates: June 23, 2017; October 23, 2017; February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

 

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19) 

(PAR-17-186)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt/Submission Dates: June 23, 2017; October 23, 2017; February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Native American Research Centers for Health (NARCH) (S06)
(PAR-16-297)
National Institute of General Medical Sciences
National Cancer Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health
Application Receipt/Submission Date: June 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)

(RFA-HL-17-023)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)

(RFA-HL-17-024)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)

(RFA-HL-17-025)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)

(RFA-HL-17-026)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)

(RFA-HL-17-027)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)

(RFA-HL-17-028)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)

(RFA-HL-17-029)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)

(RFA-HL-17-030)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)

(RFA-HL-17-031)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)

(RFA-HL-17-032)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)

(RFA-HL-17-033)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)

(RFA-HL-17-034)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
(PAR-16-416)
National Cancer Institute
Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on dates
Neural Regulation of Cancer (R01)
(PAR-16-245)
National Cancer Institute
Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 22, 2018; June 27, 2018; October 27, 2018; February 22, 2019; June 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Neural Regulation of Cancer (R21)
(PAR-16-246)
National Cancer Institute
Application Receipt/Submission Dates: June 27, 2017; October 26, 2017; February 22, 2018; June 27, 2018; October 25, 2018; February 22, 2019; June 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Human-Animal Interaction (HAI) Research (R21)

(PAR-17-229)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Human-Animal Interaction (HAI) Research (R03)

(PAR-17-230)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Human-Animal Interaction (HAI) Research (R01)

(PAR-17-231)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: June 27, 2017, March 30, 2018, March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)

(PAR-17-167)
National Cancer Institute
Application Receipt/Submission Dates: June 28, 2017; October 11, 2017; February 14, 2018, June 28, 2018; October 11, 2018; February 14, 2019; June 28, 2019; October 11, 2019; February 14, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Ancillary Studies to Identify Behavioral and/or Psychological Phenotypes Contributing to Obesity (R01)
(PAR-16-304)
National Institute of Diabetes and Digestive and Kidney Diseases
Office of Behavioral and Social Science Research
Office of Disease Prevention
Application Receipt/Submission Dates: June 28, 2017; February 28, 2018; June 28, 2018; February 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Research Answers to NCI's Provocative Questions (R01)

(RFA-CA-17-017)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement

Research Answers to NCI's Provocative Questions (R21)

(RFA-CA-17-018)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement

Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01)

(RFA-CA-17-019)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01)

(RFA-CA-17-020)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01)

(RFA-CA-17-021)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50)

(RFA-CA-17-022)
National Cancer Institute
Application Receipt Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) 

(RFA-HD-18-019)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R21)

(RFA-HD-18-020)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Centers of Excellence for Training in Glycosciences (K12)

(RFA-HL-18-013)
National Heart, Lung, and Blood Institute
Application Receipt Date: June 29, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

National Centers for Cryoelectron Microscopy (U24)

(RFA-RM-17-002)
NIH Roadmap Initiatives
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Environmental influences on Placental Origins of Development (ePOD) (R01)

(RFA-ES-17-005)
National Institute of Environmental Health Sciences
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDDK Central Repositories Non-renewable Sample Access (X01)
(PAR-14-301)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date: June 30, 2017 

Data Coordinating Center for the NICHD Neonatal Research Network (U24)

(RFA-HD-18-010)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01)

(RFA-HD-18-002)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43) 

(RFA-HD-18-028)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date: June 30, 2017, by 5:00 PM local time of applicant organization

Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp)

(PA-17-286)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: June 30, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Identification of Genetic and Genomic Variants by Next-Gen in Sequencing Non-human Animal Models (U01)
(PAR-15-120)
National Institute on Drug Abuse
Application Receipt/Submission Dates: June 30, 2017; October 20, 2017; March 1, 2018, by 5:00 PM local time of applicant organization. 
Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)
(PA-16-328)
National Center for Advancing Translational Sciences
Application Receipt/Submission Dates: July 1, 2017; November 1, 2017; March 1, 2018; July 1, 2018; November 1, 2018; March 1, 2019 by 5:00 PM local time of applicant organization
NEI Administrative Supplements to Small Business Innovative Research (SBIR) Grants for the Procurement of Expertise in the Federal Regulatory Approval Process for New Drugs and/or Devices (Admin Supp)
(PA-15-132)
National Eye Institute
Application Receipt/Submission Date: July 1, 2017, by 5:00 PM local time of applicant organization. 
Noise-Induced Cochlear Synaptopathy: Basic Studies Informing Potential Therapies (R01)
(PAR-16-170)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Date: July 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NIDCR Dental Specialty and PhD Program (DSPP)(K12)

(RFA-DE-18-003)
National Institute of Dental and Craniofacial Research
Application Receipt Date: July 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01)
(PAR-15-115)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Dates: July 3, 2017, November 1, 2017, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
(PAR-16-447)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Dates: July 3, 2017; November 1, 2017; March 2, 2018; July 2, 2018; November 1, 2018; March 1, 2019; July 1, 2019;November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIAMS Clinical Trial Planning Grant (R34)
(PAR-16-446)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Dates: July 3, 2017; November 1, 2017; March 2, 2018; July 2, 2018; November 1, 2018; March 1, 2019; July 1, 2019; November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Testing Interventions for Health-Enhancing Physical Activity (R01)
(PAR-14-315)
Office of Disease Prevention
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Resubmission application: July 5, 2017
AIDS Application Due Date: September 7, 2017 
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
(PAR-17-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Dates: July 5, 2017 (renewal, resubmission, revision); October 5, 2017 (new) and November 5, 2017 (renewal, resubmission, revision); June 5, 2018 (new) and July 5, 2018 (renewal, resubmission, revision); October 5, 2018 (new) and November 5, 2018 (renewal, resubmission, revision); June 5, 2019 (new) and July 5, 2019 (renewal, resubmission, revision); October 5, 2019 (new) and November 5, 2019 (renewal, resubmission, revision), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)

(PAR-17-236)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: July 5, 2017 (renewal, resubmission, revision); October 5, 2017 (new) and November 5, 2017 (renewal, resubmission, revision); June 5, 2018 (new) and July 5, 2018 (renewal, resubmission, revision); October 5, 2018 (new) and November 5, 2018 (renewal, resubmission, revision); June 5, 2019 (new) and July 5, 2019 (renewal, resubmission, revision); October 5, 2019 (new) and November 5, 2019 (renewal, resubmission, revision), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)

(RFA-HL-18-014)
National Heart, Lung, and Blood Institute
Application Receipt Date: July 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates

PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)

(PAR-17-257)
National Institute of Mental Health
Application Receipt/Submission Dates: July 6, 2017, June 6, 2018, June 6, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (Collaborative U01)

(PAR-17-258)
National Institute of Mental Health
Application Receipt/Submission Dates: July 6, 2017, June 6, 2018, June 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44)

(RFA-CA-17-024)
National Cancer Institute
Application Receipt Date: July 6, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Integrative Computational Biology for Analysis of NHLBI TOPMed Data

(RFA-HL-18-020)
National Heart, Lung, and Blood Institute
Application Receipt Dates: July 6, 2017 and July 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH3)
(PAR-15-096)
National Cancer Institute
Application Receipt/Submission Dates: July 7, 2017; October 6, 2017, by 5:00 PM local time of applicant organization.
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
(PAR-15-095)
National Cancer Institute
Application Receipt/Submission Dates: July 7, 2017; October 6, 2017, by 5:00 PM local time of applicant organization.
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (Admin Supp)
(PA-15-264)
National Cancer Institute
Application Receipt/Submission Dates: July 7, 2017; October 6, 2017; March 26, 2018; July 8, 2018, by 5:00 PM local time of applicant organization. 
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33)
(RFA-AR-17-009)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: July 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
Imaging and Biomarkers for Early Cancer Detection (U01)
(PAR-16-089)
National Cancer Institute
Application Receipt/Submission Dates: July 10, 2017; December 11, 2017; July 10, 2018; December 11, 2018, by 5:00 PM local time of applicant organization

Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)

(RFA-AR-18-005)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: July 10, 2017, by 5:00 PM local time of applicant organization. Late applications will not be accepted

Time-Sensitive Obesity Policy and Program Evaluation (R01)
(PAR-15-346)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Science Research
Application Receipt/Submission Dates: July 10, 2017; August 10, 2017; September 11, 2017; October 10, 2017; November 13, 2017; December 11, 2017; January 1, 2018; February 13, 2018; March 13, 2018; April 10, 2018; May 10, 2018; June 11, 2018; July 10, 2018; August 10, 2018; and September 13, 2018, by 5:00 PM local time of applicant organization.
Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01)
(PAR-15-307)
National Cancer Institute
Application Receipt/Submission Dates: July 11, 2017, November 21, 2017; July 11, 2018, by 5:00 PM local time of applicant organization. 
Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01)
(PAR-15-308)
National Cancer Institute
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: July 11, 2017, November 21, 2017; July 11, 2018, by 5:00 PM local time of applicant organization. 
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)
(PAR-17-003)
National Cancer Institute
Application Receipt/Submission Dates: July 11, 2017; October 27, 2017; February 27, 2018; July 11, 2018; October 26, 2018; February 27, 2019; July 11, 2019; October 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

(PAR-17-234)
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Nursing Research
Office of Research on Women's Health
Application Receipt/Submission Dates: July 11, 2017, July 11, 2018, July 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21)

(PAR-17-235)
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Office of Research on Women's Health
Application Receipt/Submission Dates: July 11, 2017, July 11, 2018, July 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)

(PAR-17-274)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: July 11, 2017 and then Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Genomic Community Resources (U24)

(PAR-17-273)
National Human Genome Research Institute
National Cancer Institute
Application Receipt/Submission Date: The first due date is July 13, 2017; Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)
(PAR-15-131)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date: July 14, 2017
HIV Vaccine Research and Design (HIVRAD) Program (P01)
(PAR-15-164)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: July 14, 2017, by 5:00 PM local time of applicant organization. 
Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)
(PAR-16-111)
National Cancer Institute
Application Receipt/Submission Dates: July 14, 2017; December 14, 2017, by 5:00 PM local time of applicant organization

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)

(RFA-DK-17-507)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date: July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)

(RFA-DK-17-508)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date: July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1)
(RFA-RM-15-003)
NIH Roadmap Initiatives
Application Receipt Dates: July 14, 2017; September 15, 2017; November 15, 2017; January 15, 2018
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01)
(PAR-16-455)
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: July 18, 2017; November 13, 2017; July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34)
(PAR-16-456)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: July 18, 2017; November 13, 2017; July 17, 2018; November 13, 2018; July 17, 2019; November 13, 2019; July 17, 2020; November 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Reducing the Duration of Untreated Psychosis in the United States (R34)
(PAR-16-264)
National Institute of Mental Health
Application Receipt/Submission Dates: July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Reducing the Duration of Untreated Psychosis in the United States (R01)
(PAR-16-265)
National Institute of Mental Health
Application Receipt/Submission Dates: July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54)

(RFA-OD-17-002)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
Food and Drug Administration
National Institute on Drug Abuse
Office of Disease Prevention
Application Receipt Date: July 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)

(RFA-OD-17-003)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
Food and Drug Administration
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date: July 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)

(RFA-OD-17-006)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date: July, 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

NCI Clinical and Translational Exploratory/Developmental Studies (R21)
(PAR-16-176)
National Cancer Institute
Application Receipt/Submission Dates: July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Alzheimer's-related Resource Centers for Minority Aging Research (AD-RCMAR) (P30)

(RFA-AG-18-002)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Resource Centers for Minority Aging Research (P30)

(RFA-AG-18-003)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24)

(RFA-AG-18-004)
National Institute on Aging
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Cystic Fibrosis Research and Translation Center (P30)

(RFA-DK-17-007)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NINR Clinical Trial Planning Grant (R34)

(PAR-17-133)
National Institute of Nursing Research
Application Receipt/Submission Dates: July 24, 2017, November 24, 2017, March 23, 2018, July 24, 2018, November 26, 2018, March 25, 2019, July 24, 2019, November 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
(PAR-16-430)
National Institute on Drug Abuse
Application Receipt/Submission Dates: July 25, 2017; March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Research Education Program Grants for CryoEM Curriculum Development (R25)

(RFA-RM-17-004)
NIH Roadmap Initiatives
National Eye Institute
Application Receipt Date: July 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

(RFA-DA-18-003)
National Institute on Drug Abuse
Application Receipt Dates: July 25 2017; July 25, 2018; July 25, 2019; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Grand Opportunity in Medications Development for Substance-Use Disorders (U01)
(PAR-16-431)
National Institute on Drug Abuse
Application Receipt/Submission Dates: July 25, 2017; March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp)

(PA-17-143)
National Cancer Institute
Application Receipt/Submission Dates: July 25, 2017; and December 12, 2017, by 5:00 PM local time of applicant organization

Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24)

(RFA-MH-18-250)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: July 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Data Coordinating Center (U24)

(RFA-MH-18-251)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date: July 26,2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Global Infectious Disease Research Training Program (D43)
(PAR-17-057)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: July 27, 2017; July 26, 2018; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Planning Grant for Global Infectious Disease Research Training Program (D71)
(PAR-17-058)
John E. Fogarty International Center
Application Receipt/Submission Dates: July, 27, 2017; July 26, 2018; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

SBIR E-learning for HAZMAT and Emergency Response (R43/R44) 

(RFA-ES-17-004)
National Institute of Environmental Health Sciences
Application Receipt Date: July 28, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3)
(PAR-15-267)
National Institute on Drug Abuse
Application Receipt/Submission Dates: July 28, 2017; March 28, 2018, by 5:00 PM local time of applicant organization.

NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)

(RFA-DA-18-001)
National Institute on Drug Abuse
Application Receipt Dates: July 31, 2017, July 31, 2018, July 31, 2019, by 5:00 PM local time of applicant organization

Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21)
(PAR-16-343)
National Center for Advancing Translational Sciences
Application Receipt/Submission Dates: July 31, 2017, November 29, 2017, March 29, 2018, July 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Cellular Therapies for Treatment of Radiation Injuries (U01) 

(RFA-AI-17-001)
National Institute of Allergy and Infectious Diseases
Application Receipt Date: August 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)

(RFA-AI-17-010)
National Institute of Allergy and Infectious Diseases
Application Receipt Date: August 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Innovation for HIV Vaccine Discovery (R01)

(PAR-17-263)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: August 1, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Centers for AIDS Research (P30)

(PAR-17-237)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt/Submission Dates: August 1, 2017; August 17, 2018; August 17, 2019 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Developmental Centers for AIDS Research (P30)

(PAR-17-238)
National Institute of Allergy and Infectious Diseases
John E. Fogarty International Center
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt/Submission Dates: August 1, 2017; August 17, 2018; August 17, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

AHRQ Conference Grant Programs (R13)
(PA-16-453)
Agency for Healthcare Research and Quality
Application Receipt/Submission Dates: August 1 and November 1 by 5:00 PM local time of applicant organization
BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science (R25)
(RFA-HG-16-016)
National Human Genome Research Institute
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Science Research
Office of Disease Prevention
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
The Common Fund/Office of Strategic Coordination
Application Receipt Dates: August 2, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
NeuroNEXT Clinical Trials (U01)
(PAR-16-155)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: August 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)

(RFA-AT-18-001)
National Center for Complementary and Integrative Health
Application Receipt Date: August 4, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Regional Consortia for High Resolution Cryoelectron Microscopy (U24)

(RFA-GM-17-005)
National Institute of General Medical Sciences
Application Receipt Date: August 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (PRECluDE) (U01)

(RFA-HL-18-007)
National Heart, Lung, and Blood Institute
Application Receipt Date: August 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34)

(PAR-17-268)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: August 7, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)

(PAR-17-187)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)

(PAR-17-188)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01)

(PAR-17-189)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)

(RFA-AR-18-002)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Dates: August 7, 2017; December 4, 2017; April 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R21)

(RFA-AR-18-003)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Sleep Health and Circadian Biology in HIV-Related Comorbidities (R01)

(RFA-HL-18-005)
National Heart, Lung, and Blood Institute
Application Receipt Date: August 9, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

(PAR-17-201)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: August 9, 2017, Feb 6, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)

(PAR-17-205)
National Institute of Neurological Disorders and Stroke
NIH Blueprint for Neuroscience Research
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Application Receipt/Submission Dates: August 9, 2017, Feb 7, 2018, Aug 9, 2018, Feb 9, 2019, August 9, 2019, Feb 11, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Palliative Care Research Cooperative (PCRC) (U2C)

(RFA-NR-17-001)
National Institute of Nursing Research
Application Receipt Date: August 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44)

(RFA-DA-18-010)
National Institute on Drug Abuse
Application Receipt Date: August 15, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
(PAR-15-297)
National Cancer Institute
Application Receipt/Submission Dates: August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization. 

Extracellular Vesicles and Substance Use Disorders (R21)

(PAR-17-242)
National Institute on Drug Abuse
Application Receipt/Submission Dates: August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Extracellular Vesicles and Substance Use Disorders (R01)

(PAR-17-250)
National Institute on Drug Abuse
Application Receipt/Submission Dates: August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Inter-organelle Communication in Cancer (R01)

(PAR-17-203)
National Cancer Institute
Application Receipt/Submission Dates: August 16, 2017; January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Inter-organelle Communication in Cancer (R21)

(PAR-17-204)
National Cancer Institute
Application Receipt/Submission Dates: August 16, 2017, January 17, 2018; August 15, 2018; January 16, 2019; August 14, 2019; January 15, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
(PAR-16-020)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: August 17, 2017; February 15, 2018; August 17, 2018, by 5:00 PM local time of applicant organization

Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01)

(RFA-DA-18-008)
National Institute on Drug Abuse
Application Receipt Date: August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21)

(RFA-DA-18-009)
National Institute on Drug Abuse
Application Receipt Date: August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date

Tobacco Regulatory Science (R01)

(RFA-OD-17-007)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Regulatory Science Small Grant Program for New Investigators (R03)

(RFA-OD-17-008)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Tobacco Regulatory Science (R21)

(RFA-OD-17-009)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Dates: August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3)

(RFA-NS-17-023)
National Institute of Neurological Disorders and Stroke
Application Receipt Date: August 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late Applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)

(RFA-DA-18-002)
National Institute on Drug Abuse
Application Receipt Dates: August 22, 2017; August 22, 2018; August 22, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36)
(PAR-15-181)
National Institute of Mental Health
Application Receipt/Submission Dates: August 22, 2017, December 22, 2017, April 23, 2018, by 5:00 PM local time of applicant organization.

Nasal Delivery of CNS Therapeutics (R43/R44) 

(RFA-DA-18-006)
National Institute on Drug Abuse
Application Receipt Date: August 23, 2017, by 5:00 PM local time of applicant organization

Nasal Delivery of CNS Therapeutics (R41/R42) 

(RFA-DA-18-007)
National Institute on Drug Abuse
Application Receipt Date: August 23, 2017, by 5:00 PM local time of applicant organization

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43)
(PAR-16-279)
John E. Fogarty International Center
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt/Submission Dates: August 23, 2017; August 23, 2018), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11)
(PAR-16-280)
John E. Fogarty International Center
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt/Submission Dates: August 23, 2017; August 23, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71)
(PAR-16-281)
John E. Fogarty International Center
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt/Submission Dates: August 23, 2017; August 23, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Lasker Clinical Research Scholars Program Si2/R00

(PAR-17-254)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Application Receipt/Submission Date: August 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21)
(PAR-16-292)
John E. Fogarty International Center
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Science Research
Application Receipt/Submission Date: August 31, 2017; August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp)
(PA-16-013)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates: April 1 and September 1, 2016-2018 by 5:00 PM local time of applicant organization

NIH Director's Pioneer Award Program (DP1)

(RFA-RM-17-005)
NIH Roadmap Initiatives
The Common Fund/Office of Strategic Coordination
Application Receipt Date: September 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)

(RFA-MH-18-300)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date: September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21)

(RFA-MH-18-301)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date: September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Biomarkers Discovery In Parkinsonism (U01)
(PAR-16-112)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: September 6, 2017; September 6, 2018, by 5:00 PM local time of applicant organization
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01)
(PAR-16-254)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: September 6, 2017; September 6, 2018 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Biological Comparisons in Patient-Derived Models of Cancer (U01)
(PAR-16-344)
National Cancer Institute
Application Receipt/Submission Dates: September 6, 2017; March 7, 2018; September 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25)
(PAR-15-145)
National Institute of Mental Health
Application Receipt/Submission Date: Sepember 7, 2017, by 5:00 PM local time of applicant 
Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R21)
(PAR-15-275)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Mental Health
Application Receipt/Submission Dates: September 7, 2017; January 8, 2018, by 5:00 PM local time of applicant organization. 
Ethical Issues in Research on HIV/AIDS and its Co-Morbidities (R01)
(PAR-15-274)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Mental Health
Application Receipt/Submission Dates: September 7, 2017; January 8, 2018, by 5:00 PM local time of applicant organization. 
Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21)
(PAR-15-327)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt/Submission Dates: September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. 
Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01)
(PAR-15-328)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt/Submission Dates: September 7, 2017; January 8, 2018; September 7, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. 

NIH Director's New Innovator Award Program (DP2)

(RFA-RM-17-006)
NIH Roadmap Initiatives
Application Receipt Date: September 8, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15)
(PAR-15-149)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: September 11, 2017, by 5:00 PM local time of applicant organization. 
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
(PAR-15-146)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: September 12, 2017, by 5:00 PM local time of applicant organization. 

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)

(PAR-17-128)
National Cancer Institute
Application Receipt/Submission Date: September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
(PAR-16-128)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
(PAR-16-129)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
(PAR-16-329)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: September 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
(PAR-16-330)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
(PAR-16-331)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)

(PAR-17-129)
National Cancer Institute
Application Receipt/Submission Date: September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Bioengineering Research Partnerships (U01)
(PAR-16-116)
National Institute of Biomedical Imaging and Bioengineering
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: September 13, 2017, May 8, 2018, September 13, 2018, by 5:00 PM local time of applicant organization
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)
(PAR-16-301)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: September 13, 2017; January 11, 2018; May 13, 2018; September 13, 2018; January 11, 2019; May 13, 2019; September 13, 2019 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates
NIAID Clinical Trial Implementation Grant (R01)
(PAR-16-269)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIAID Clinical Trial Implementation Cooperative Agreement (U01)
(PAR-16-270)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)
(PAR-16-271)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization
NIAID Clinical Trial Planning Grant (R34)
(PAR-16-272)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Developmental AIDS Research Center on Mental Health and HIV/AIDs (P30)
(PAR-15-196)
National Institute of Mental Health
Application Receipt/Submission Date: September 14, 2017, by 5:00 PM local time of applicant organization. 
AIDS Research Center on Mental Health and HIV/AID (P30)
(PAR-15-197)
National Institute of Mental Health
Application Receipt/Submission Date: September 14, 2017 by 5:00 PM local time of applicant organization. 

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) 

(RFA-TR-17-002)
National Center for Advancing Translational Sciences
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) 

(RFA-TR-17-003)
National Center for Advancing Translational Sciences
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No Late applications will be accepted for this FOA

NIH Director's Transformative Research Awards (R01)

(RFA-RM-17-007)
NIH Roadmap Initiatives
The Common Fund/Office of Strategic Coordination
Application Receipt Date: September 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25)
(RFA-HL-16-008)
National Heart, Lung, and Blood Institute
Application Receipt Date: September 18, 2017 
T32 Training Program for Institutions That Promote Diversity (T32)
(RFA-HL-16-007)
National Heart, Lung, and Blood Institute
Application Receipt Date: September 18, 2017 (resubmissions only) by 5:00 PM local time of applicant organization. 
Institutional Research and Academic Career Development Awards (IRACDA) (K12)
(PAR-16-103)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization
Biophysical and Biomechanical Aspects of Embryonic Development (R21)
(PAR-16-324)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Biophysical and Biomechanical Aspects of Embryonic Development (R01)
(PAR-16-325)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: September 19, 2017; September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01)
(PAR-15-021)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date: September 21, 2017
Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01)
(PAR-15-108)
National Cancer Institute
Application Receipt/Submission Date: September 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) 

(PAR-17-146)
National Cancer Institute
Application Receipt/Submission Date: September 21, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

The Pancreatic Cancer Detection Consortium (U01)
(PAR-15-289)
National Cancer Institute
Application Receipt/Submission Dates: September 21, 2017, April 6, 2018, by 5:00 PM local time of applicant organization. 

NIH Director's Early Independence Awards (DP5)

(RFA-RM-17-008)
NIH Roadmap Initiatives
Application Receipt Date: September 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90)
(PAR-15-101)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. 
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32)
(PAR-15-102)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. 

NIH StrokeNet Regional Coordinating Stroke Centers (U24)

(PAR-17-276)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date: September 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIDA Research Center of Excellence Grant Program (P50)
(PAR-16-009)
National Institute on Drug Abuse
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. 
Bridges to the Doctorate (R25)
(PAR-16-109)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018. If the date falls on a week-end, the application is due the next business day, by 5:00 PM local time of applicant organization
Bridges to the Baccalaureate (R25)
(PAR-16-110)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017 September 25, 2018, by 5:00 PM local time of applicant organization

Research Education: Bridges to the Doctorate (R25)

(PAR-17-209)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Bridges to the Baccalaureate Program (R25)

(PAR-17-210)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 25, 2017; September 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)

(PA-17-247)
Agency for Healthcare Research and Quality
Application Receipt/Submission Dates: September 25, 2017, September 25, 2018, and September 26, 2019), by 5:00 PM local time of applicant organization

NIDA Core "Center of Excellence" Grant Program (P30)

(PAR-17-121)
National Institute on Drug Abuse
Application Receipt/Submission Dates: September 26, 2017; September 26, 2018, September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

nitiative to Maximize Research Education in Genomics: Courses for Skills Development (R25)
(PAR-16-090)
National Human Genome Research Institute
Application Receipt/Submission Dates: September 26, 2017; January 25, 2018; May 25, 2018; September 26, 2018; and January 25, 2019, by 5:00 PM local time of applicant organization
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
(RFA-CA-17-010)
National Cancer Institute
Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
(RFA-CA-17-013)
National Cancer Institute
Application Receipt Dates: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
(RFA-CA-17-012)
National Cancer Institute
Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
(RFA-CA-17-011)
National Cancer Institute
Application Receipt Date: September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Perception and Cognition Research to Inform Cancer Image Interpretation (R21)

(PAR-17-124)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Perception and Cognition Research to Inform Cancer Image Interpretation (R01)

(PAR-17-125)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Animal Species (R01)
(PAR-16-366)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Department of Agriculture
Application Receipt/Submission Dates: September 27, 2017; September 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NICHD Laboratory of Developmental Biology (R24)
(PAR-16-396)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: September 27, 2017, January 30, 2018, May 30, 2018, September 26, 2018, January 30, 2019, May 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01)

(RFA-DE-18-005)
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R21)

(RFA-DE-18-006)
National Institute of Dental and Craniofacial Research
Application Receipt Date: September 28, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20)
(PAR-16-241)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: September 28, 2017; and September 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)
(PAR-15-085)
National Institute of Biomedical Imaging and Bioengineering
Department of Energy
Food and Drug Administration
National Aeronautics and Space Administration
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Science Foundation
Office of Behavioral and Social Science Research
Office of Naval Research
US Army
Application Receipt/Submission Dates: September 29, 2017 (Applicants interested in DOE funding may wish to use the September due dates, see Section IV.6, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIDCD Clinical Research Center Grant (P50)
(PAR-16-339)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Dates: October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Novel Cell Non-autonomous Mechanisms of Aging (R01)

(RFA-AG-18-009)
National Institute on Aging
Application Receipt Date: October 3, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (FI2)
(PAR-15-094)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

Maximizing Investigators' Research Award for Early Stage Investigators (R35)

(PAR-17-190)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 3, 2017; October 3, 2018; October 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (Fi2)
(PA-16-130)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 3, 2017; October 3, 2018, by 5:00 PM local time of applicant organization

NIAMS Rheumatic Diseases Research Resource-based Centers (P30)

(RFA-AR-18-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: October 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01)

(PAR-17-215)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications:
 October 3, 2017; February 2, 2018; June 1, 2018; October 3, 2018; February 1, 2019; May 31, 2019; October 3, 2019; and January 31, 2020
Resubmission, Revision, and Renewal Applications: October 18, 2017, February 20, 2018, June 14, 2018, October 17, 2018, February 15, 2019, June 14, 2019, October 17, 2019, February 14, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)

(PAR-17-093)
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: October 3, 2017; March 1, 2018; June 7, 2018; October 3, 2018; March 1, 2019; June 7, 2019; October 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Informatics Methodology and Secondary Analyses to Explore Shared Immunology Study Data in ImmPort (UH2)
(PAR-16-253)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: October 4, 2017; October 4, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Selected Topics in Transfusion Medicine (R01)
(PAR-16-440)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 5, 2017; February 5, 2018; October 5, 2018; February 5, 2019; October 5, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Diet and Physical Activity Assessment Methodology (R01)
(PAR-15-170)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Office of Dietary Supplements
Application Receipt/Submission Dates: 
For new applications: October 5, 2017; and June 5, 2018 (alternating standard R01 receipt dates).
For resubmission/renewal/revision applications: November 5, 2017; and July 5, 2018 (alternating standard R01 receipt dates) , by 5:00 PM local time of applicant organization. 

Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24)

(PAR-17-172)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications:
October 6, 2017; June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and Revision Applications: June 21, 2018, February 21, 2019, and October 21, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3)

(PAR-17-174)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications:
October 6, 2017; June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and revision Applications: June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01)

(PAR-17-216)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: 
October 6, 2017; June 7, 2018; February 7, 2019; and October 8, 2019
Resubmission, Revision, and Renewal Applications: October 20, 2017; June 21, 2018; February 21, 2019; and October 21, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NIDCD Research Career Enhancement Award for Established Investigators (K18)
(PAR-16-346)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Dates: October 6, 2017; February 8, 2018; June 8, 2018; October 9, 2018; February 8, 2019; and June 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Building Evidence: Effective Palliative/End of Life Care Interventions (R01)
(PAR-16-250)
National Institute of Nursing Research
Application Receipt/Submission Dates: October 9, 2017; June 11, 2018; October 8, 2018; June 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30)
(PAR-16-247)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 10, 2017; October 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Environmental Health Cohorts Maintenance and Infrastructure (R24)
(RFA-ES-16-004)
National Institute of Environmental Health Sciences
Application Receipt Dates: October 10, 2017; October 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01)
(PAR-16-380)
National Cancer Institute
Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019, October 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)
(PAR-16-257)
National Cancer Institute
Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)
(PAR-16-317)
National Cancer Institute
Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21)
(PAR-16-318)
National Cancer Institute
Application Receipt/Submission Dates: October 10, 2017; April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34)
(PAR-15-117)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Date: October 10, 2017, by 5:00 PM local time of applicant organization. 
NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)
(PAR-15-116)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Date: October 10, 2017, by 5:00 PM local time of applicant organization. 
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R24)
(RFA-MH-17-256)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date: October 11, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Identification of Mechanisms Mediating the Effects of Sleep on Diabetes-Related Metabolism in Humans (R01)
(RFA-DK-16-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Office of Research on Women's Health
Application Receipt Date: October 11, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21)
(PAR-16-248)
National Cancer Institute
Application Receipt/Submission Dates: October 11, 2017; June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01)
(PAR-16-249)
National Cancer Institute
Application Receipt/Submission Dates: October 11, 2017; June 13, 2018; October 11, 2018, June 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)
(PAR-16-300)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 11, 2017; February 13, 2018; June 13, 2018; October 11, 2018; February 13, 2019; June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
FDA Scientific Conference Grant Program (R13)
(PAR-16-378)
Food and Drug Administration
Application Receipt/Submission Dates: October 12, 2017 by 11:59 PM Eastern Time. April 12, 2018 and October 12, 2018 by 11:59 PM Eastern Time. April 12, 2019 and October 11, 2019 by 11:59 PM Eastern Time
Occupational Safety and Health Education and Research Centers (T42)
(PAR-15-303)
National Institute for Occupational Safety and Health
Application Receipt/Submission Dates: October 13, 2017, October 11, 2018, October 18, 2019 by 5:00 PM EST. 
BRAIN Initiative Cell Census Network (BICCN) - Specialized Center on Human and Non-Human Primate Brain Cell Atlases (U01)
(RFA-MH-17-210)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Dates: October 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)
(RFA-HL-17-015)
National Heart, Lung, and Blood Institute
Application Receipt Date: October 13, 2017; January 10, 2018; May 10, 2018; October 10, 2018; January 10, 2019; May 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
BRAIN Initiative Cell Census Network (BICCN) - Specialized Center on Mouse Brain Cell Atlas (U01)
(RFA-MH-17-230)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Dates: October 13, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
(PAR-16-276)
National Cancer Institute
Application Receipt/Submission Dates: October 13, 2017; June 13, 2018; October 15, 2018; June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)
(RFA-FD-15-001)
Food and Drug Administration
Office of Orphan Products Development
Application Due Dates: February 7, 2018 by 11:59 PM Eastern Time.
Resubmission Due Dates: October 16, 2017; October 15, 2018 by 11:59 PM Eastern Time. 
Selected Topics in Transfusion Medicine (R21)
(PAR-16-441)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 16, 2017; February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Diet and Physical Activity Assessment Methodology (R21)
(PAR-15-171)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Office of Dietary Supplements
Application Receipt/Submission Dates: 
For new applications: October 16, 2017; and June 16, 2018 (alternating standard due dates). 
​For resubmission applications: November 16, 2017; and July 16, 2018 (alternating standard due dates), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
(RFA-HL-17-022)
National Heart, Lung, and Blood Institute
Application Receipt Dates: October 17, 2017; February 15, 2018; October 17, 2018; February 15, 2019; October 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19)
(RFA-NS-17-018)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01)
(RFA-NS-17-003)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)
(RFA-NS-17-004)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)
(RFA-NS-17-005)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3)
(RFA-NS-17-006)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)
(RFA-NS-17-007)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization

Basic Research in Calcific Aortic Valve Disease (R01) 

(RFA-HL-18-010)
National Heart, Lung, and Blood Institute
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

BRAIN Initiative: SBIR Direct to Phase II Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)
(RFA-NS-17-008)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Application Receipt Date: October 18, 2017, by 5:00 PM local time of applicant organization

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)

(PAR-17-184)
National Institute on Deafness and Other Communication Disorders
Application Receipt/Submission Dates: October 18, 2017; June 19, 2018; February 20, 2019; October 18, 2019; June 18, 2020; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24)
(PAR-16-104)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: October 18, 2017; October 18, 2018, by 5:00 PM local time of applicant organization
Big Data to Knowledge (BD2K) Community-based Data and Metadata Standards Efforts (R24)
(RFA-ES-16-010)
National Institute of Environmental Health Sciences
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
The Common Fund/Office of Strategic Coordination
Application Receipt Dates: October 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34) 

(RFA-HL-18-008)
National Heart, Lung, and Blood Institute
Application Receipt Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01)

(RFA-HL-18-009)
National Heart, Lung, and Blood Institute
Application Receipt Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
(PAR-16-268)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date: October 19, 2017; February 19, 2018; October 19, 2018; February 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1)
(PAR-16-357)
National Institute on Drug Abuse
Application Receipt/Submission Dates: October 19, 2017; October 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01) 

(PAR-17-294)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: October 19, 2017; January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24)
(RFA-MH-17-255)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)

(RFA-AG-18-006)
National Institute on Aging
Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Coordinating Center for Claude D. Pepper Older Americans Independence Centers (U24)

(RFA-AG-18-008)
National Institute on Aging
Application Receipt Date: October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Uncovering the Causes, Contexts, and Consequences of Elder Mistreatment (R01)

(RFA-AG-18-010)
National Institute on Aging
Application Receipt Date: October 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention and Care (R18)

(RFA-DK-17-008)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: October 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Psychological, Behavioral, and Neurocognitive-Focused Ancillary Studies to the Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC) (U01)

(RFA-DK-17-009)
National Institute of Diabetes and Digestive and Kidney Diseases
Office of Behavioral and Social Science Research
Application Receipt Date: October 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Occupational Safety and Health Training Project Grants (T03)
(PAR-15-352)
National Institute for Occupational Safety and Health
Application Receipt/Submission Dates: October 26, 2017; October 26, 2018; October 24, 2019 
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R24)
(RFA-MH-17-257)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date: October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Novel Genomic Technology Development (R43/R44)
(PAR-16-016)
National Human Genome Research Institute
Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization
Novel Genomic Technology Development (R21)
(PAR-16-015)
National Human Genome Research Institute
Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization
Novel Genomic Technology Development (R01)
(PAR-16-014)
National Human Genome Research Institute
Application Receipt/Submission Dates: October 31, 2017, by 5:00 PM local time of applicant organization

NIDDK Central Repositories Non-renewable Sample Access (X01)

(PAR-17-270)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: October 31, 2017; March 2, 2018; June 29, 2018; October 30, 2018; March 1, 2019; June 28, 2019; October 31, 2019; March 3, 2020; and June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

George M. O'Brien Kidney Research Core Centers (P30)

(RFA-DK-17-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: November 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Tobacco Use and HIV in Low and Middle Income Countries (R01)
(PAR-17-087)
National Cancer Institute
National Institute on Drug Abuse
Application Receipt/Submission Dates: November 1, 2017; April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Tobacco Use and HIV in Low and Middle Income Countries (R21)
(PAR-17-086)
National Cancer Institute
National Institute on Drug Abuse
Application Receipt/Submission Dates: November 1, 2017; April 4, 2018; November 1, 2018; April 4, 2019, November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)

(PAR-17-178)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)

(PAR-17-177)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)

(PAR-17-180)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2)
(PAR-16-126)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Dates: November 1, 2017; June 1, 2018; November 1, 2018, by 5:00 PM local time of applicant organization

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)

(RFA-DK-17-006)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01)

(RFA-MH-18-400)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Office of Behavioral and Social Science Research
Application Receipt Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)

(PAR-17-293)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date: November 2, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. ***This FOA is being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. This FOA will be reissued for additional due date(s) on or after January 25, 2018.***. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)
(PA-15-109)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt/Submission Date: November 6, 2017 by 5:00 PM local time of applicant organization. 

Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)

(PA-17-138)
National Cancer Institute
Application Receipt/Submission Dates: November 8, 2017; March 28, 2018, by 5:00 PM local time of applicant organization

NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
(RFA-ES-15-016)
National Institute of Environmental Health Sciences
Application Receipt Dates: November 13, 2017, by 5:00 PM local time of applicant organization. 

Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)

(RFA-DA-18-004)
National Institute on Drug Abuse
Application Receipt Dates: Nov 13, 2017; Nov 13, 2018, Nov 13, 2019 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Social Epigenomics Research Focused on Minority Health and Health Disparities (R21)
(PAR-16-356)
National Institute on Minority Health and Health Disparities
National Cancer Institute
Application Receipt/Submission Dates: November 15, 2017; November 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)
(PAR-16-049)
National Cancer Institute
Application Receipt/Submission Dates: November 17, 2017, March 17, 2018; November 17, 2018, by 5:00 PM local time of applicant organization.
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24)
(PAR-16-385)
National Cancer Institute
Application Receipt/Submission Dates: November 17, 2017; June 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Innovative Research in Cancer Nanotechnology (IRCN) (R01)

(PAR-17-240)
National Cancer Institute
Application Receipt/Submission Dates: November 21, 2017; May 23, 2018; November 20, 2018; May 23, 2019, November 21, 2019, May 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01)

(RFA-DE-18-008)
National Institute of Dental and Craniofacial Research
Application Receipt Date: November 24,2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

HIV pathogenesis and the oral microbiota (R01)

(RFA-DE-18-007)
National Institute of Dental and Craniofacial Research
Application Receipt Date: November 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement

NIOSH Centers of Excellence for Total Worker Health (U19)
(PAR-15-361)
National Institute for Occupational Safety and Health
Application Receipt/Submission Dates: November 30, 2017; November 30, 2018 and November 29, 2019. 
New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3)
(PAR-16-349)
National Cancer Institute
Application Receipt/Submission Dates: November 30, 2017; April 16, 2018; November 30, 2018; April 16, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)
(PAR-16-105)
National Cancer Institute
Application Receipt/Submission Dates: November 30, 2017; May 30, 2018; November 30, 2018, by 5:00 PM local time of applicant organization
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
(PAR-16-098)
National Institute for Occupational Safety and Health
Application Receipt/Submission Dates: December 1, 2017; December 4, 2018; December 3, 2019
BD2K Research Education Curriculum Development: Data Science Overview for Biomedical Scientists (R25)
(RFA-ES-16-011)
National Institute of Environmental Health Sciences
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Office of Behavioral and Social Science Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
The Common Fund/Office of Strategic Coordination
Application Receipt Dates: December 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Specialized Alcohol Research Centers (P50) 

(RFA-AA-18-001)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date: December 5, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date

Silencing of HIV-1 Proviruses (R61/R33)

(RFA-AI-17-013)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date: December 6, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Wearable Alcohol Biosensors (R43/R44)
(PAR-16-410)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: December 6, 2017; April 4, 2018; December 6, 2018; April 4, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Investigator Initiated Extended Clinical Trial (R01)
(PAR-17-056)
National Institute of Allergy and Infectious Diseases
National Institute on Aging
National Institute of General Medical Sciences
Application Receipt/Submission Dates: December 7, 2017; March 7, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2)
(PAR-15-073)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date: December 11, 2017, by 5:00 PM local time of applicant organization. 
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2)
(PAR-15-153)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date: December 11, 2017 , by 5:00 PM local time of applicant organization. 
Emerging Global Leader Award (K43)
(PAR-15-292)
John E. Fogarty International Center
National Human Genome Research Institute
National Institute of Environmental Health Sciences
National Institute of Mental Health
Application Receipt/Submission Date: December 14, 2017, by 5:00 PM local time of applicant organization. 
Emerging Global Leader Award (K43)
(PAR-17-001)
John E. Fogarty International Center
National Cancer Institute
National Human Genome Research Institute
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt/Submission Dates: December 14, 2017; and December 13, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02)
(PAR-15-286)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Dietary Supplements
Office of Research on Women's Health
Application Receipt/Submission Date: December 15, 2017, by 5:00 PM local time of applicant organization. 
Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01)
(RFA-HL-18-004)
National Heart, Lung, and Blood Institute
Application Receipt Date: December 15, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01)
(PAR-16-262)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt/Submission Dates: January 4, 2018; January 4, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01)
(PAR-16-115)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt/Submission Date: January 9, 2018; May 8, 2018; January 9, 2019, by 5:00 PM local time of applicant organization
HIV/AIDS Vaccine Scholars Program (K01)
(PAR-16-347)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
HIV/AIDS Vaccine Scholars Program (K01)
(PAR-16-028)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)
(PAR-15-360)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date: January 11, 2018, by 5:00 PM local time of applicant organization. 
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (U44)
(PAR-15-074)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date: December 11, 2017, by 5:00 PM local time of applicant organization.
Cardiovascular and Pulmonary Research on E-Cigarettes (R01)
(RFA-HL-17-021)
National Heart, Lung, and Blood Institute
Application Receipt Date: January 16, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Maximizing Investigators' Research Award (R35)

(PAR-17-094)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 17, 2018; May 17, 2018; January 17, 2019; May 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)
(PAR-16-021)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: January 19, 2018; January 18, 2019, by 5:00 PM local time of applicant organization
Innovative Programs to Enhance Research Training (IPERT) (R25)
(PAR-17-070)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 23, 2018; January 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Centers of Biomedical Research Excellence (COBRE) (P20)
(PAR-16-415)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 24, 2018; and January 24, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Postbaccalaureate Research Education Program (PREP) (R25)
(PAR-17-051)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 24, 2018; January 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Support of NIGMS Program Project Grants (P01)
(PAR-16-433)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 25, 2018; and May 25, 2018 by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32)
(PAR-17-072)
National Institute on Aging
National Institute of Nursing Research
Application Receipt/Submission Dates: January 25, 2018; and January 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIA Program Project Applications (P01)
(PAR-16-358)
National Institute on Aging
Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Support of Competitive Research (SCORE) Research Continuance Award (SC3)
(PAR-16-437)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Support of Competitive Research (SCORE) Pilot Project Award (SC2)
(PAR-16-438)
National Institute of General Medical Sciences
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: January 25, 2018; May 25, 2018; January 25, 2019; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Limited Competition: Research Resource for Human Organs and Tissues (U42)
(RFA-OD-17-001)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: January 26, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)
(PAR-17-053)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 26, 2018; and January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)
(PAR-17-040)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: January 26, 2018; and January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)
(PAR-16-084)
National Cancer Institute
Application Receipt/Submission Date: January 29, 2018, by 5:00 PM local time of applicant organization
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)
(PAR-15-315)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Environmental Health Sciences
Application Receipt/Submission Date: January 30, 2018, by 5:00 PM local time of applicant organization. 
Summer Research Experiences for Students and Science Teachers (Admin Supp)
(PA-17-055)
National Institute of Environmental Health Sciences
Application Receipt/Submission Dates: January 31, 2018, and January 31, 2019 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33)

(PAR-17-162)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates: February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017; February 14, 2018; October 17, 2018; June 14, 2019

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3)

(PAR-17-175)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: 
February 2, 2018; October 3, 2018; May 31, 2019; and January 31, 2020
Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Cancer-related Behavioral Research through Integrating Existing Data (R01)
(PAR-16-256)
National Cancer Institute
Application Receipt/Submission Dates: February 7, 2018; June 7 2018; February 7, 2019; June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)

(PAR-17-206)
National Cancer Institute
Application Receipt/Submission Dates: February 7, 2018; June 8, 2018; February 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24)

(PAR-17-173)
National Center for Complementary and Integrative Health
Application Receipt/Submission Dates:
New Applications: 
October 3, 2018; May 31, 2019; and January 31, 2020
Resubmission and Revision Applications: February 14, 2018; October 17, 2018; June 14, 2019; and February 14, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

NHLBI Early Investigator Award (EIA) (R35)
(RFA-HL-16-025)
National Heart, Lung, and Blood Institute
Application Receipt Date: February 15, 2018, by 5:00 PM local time of applicant organization
NHLBI Outstanding Investigator Award (OIA) (R35)
(RFA-HL-16-024)
National Heart, Lung, and Blood Institute
Application Receipt Date: February 15, 2018, by 5:00 PM local time of applicant organization

CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) 

(PAR-17-141)
Food and Drug Administration
Application Receipt/Submission Dates: February 15, 2018, February 15, 2019, by 11:59 PM Eastern Time

Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
(PAR-17-004)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Dates: February 23, 2018; February 22, 2019, by 5:00 PM local time of application organization
NLM Grants for Scholarly Works in Biomedicine and Health (G13)
(PAR-16-417)
National Library of Medicine
Application Receipt/Submission Date: February 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Outstanding New Environmental Scientist (ONES) Award (R01)
(RFA-ES-15-020)
National Institute of Environmental Health Sciences
Application Receipt Date: February 27, 2018, by 5:00 PM local time of applicant organization
NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01)
(RFA-ES-17-002)
National Institute of Environmental Health Sciences
Application Receipt Date: March 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
International Research Scientist Development Award (IRSDA) (K01)
(PAR-17-002)
John E. Fogarty International Center
National Cancer Institute
Application Receipt/Submission Dates: March 7, 2018; March 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
International Research Scientist Development Award (IRSDA) (K01)
(PAR-15-291)
John E. Fogarty International Center
Application Receipt/Submission Date: March 7, 2018 by 5:00 PM local time of applicant organization. 
Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)
(PAR-15-330)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: March 9, 2018, by 5:00 PM local time of applicant organization. 

Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71)

(PAR-17-097)
John E. Fogarty International Center
Application Receipt/Submission Dates: March 14, 2018; March 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Phylodynamic Tracking of HIV Transmission (R01)
(PAR-17-048)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt/Submission Dates: March 15, 2018; March 15, 2019 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

Data Science Research: Personal Health Libraries for Consumers and Patients (R01)

(PAR-17-159)
National Library of Medicine
Application Receipt/Submission Dates: March 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Summer Research Education Experience Programs (R25)
(PAR-15-184)
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Dates: March 23, 2018, by 5:00 PM local time of applicant organization. 
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 23, 2018, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. 

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

(PAR-17-099)
National Eye Institute
Application Receipt/Submission Dates: March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

IDeA Networks of Biomedical Research Excellence (INBRE) (P20)

(PAR-17-160)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

NCMRR Early Career Research Award (R03)

(PAR-17-161)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)

(PAR-17-163)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Application Receipt/Submission Dates: March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Integrated Food Defense & Emergency Response Cooperative Agreement Program IFD&ER (U18)
(RFA-FD-15-022)
Food and Drug Administration
Office of Foods and Veterinary Medicine/Center for Food Safety and Applied Nutrition
Application Receipt Dates: April 2, 2018; April 2, 2019 by 11:59 PM Eastern Time. 
State and Territory Cooperative Agreement to Enhance Produce Safety in Preparation of Implementation of FDA's Rule: Standards for the Growing, Harvesting, Packing, & Holding of Produce for Human Consumption (U18)
(PAR-16-137)
Food and Drug Administration
Office of Foods and Veterinary Medicine/Center for Food Safety and Applied Nutrition
Application Receipt/Submission Dates: April 3, 2018, 2019, by 11:59 PM Eastern Time

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) 

(PAR-17-151)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)

(PAR-17-150)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Dates: April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Opportunities for Collaborative Research at the NIH Clinical Center (U01)
(PAR-15-287)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Office of Dietary Supplements
Office of Research on Women's Health
Application Receipt/Submission Dates: April 11, 2018, by 5:00 PM local time of applicant organization

Environmental Health Sciences Core Centers (EHS CC) (P30)

(RFA-ES-17-003)
National Institute of Environmental Health Sciences
Application Receipt Dates: April 17, 2018, April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18)

(RFA-FD-17-010)
Food and Drug Administration
Application Receipt Date: April 17, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA

Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01)
(PAR-15-187)
Food and Drug Administration
Application Receipt/Submission Dates: April 30, 2018, by 8:00 PM Eastern Time. April 30, 2019, by 8:00 PM Eastern Time. 
Vet-LIRN Cooperative Agreement Program to Develop and Validate Testing Methods for Food Irradiation Specific Markers in Animal Feeds and Treats (U18)
(PAR-16-132)
Food and Drug Administration
Application Receipt/Submission Date: May 01, 2018
NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)
(PAR-16-099)
Food and Drug Administration
Application Receipt/Submission Dates: May 1, 2018, 2019, 2020, by 11:59 PM Eastern Time
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01)
(PAR-16-117)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt/Submission Date: May 8, 2018, by 5:00 PM local time of applicant organization
International Bioethics Research Training Program (D43)
(PAR-16-454)
John E. Fogarty International Center
Application Receipt/Submission Dates: May 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
International Research Ethics Education and Curriculum Development Award (R25)
(PAR-16-081)
John E. Fogarty International Center
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date: May 17, 2018, by 5:00 PM local time of applicant organization
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50)
(PAR-16-354)
National Institute of Mental Health
Application Receipt/Submission Date: May 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

International Research in Infectious Diseases, including AIDS (R01) 

(PAR-17-142)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Dates: May 22, 2018; May 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34)
(PAR-17-068)
National Institute of General Medical Sciences
Application Receipt/Submission Date: May 24, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25) 

(PAR-17-221)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

NIMH Mentoring Networks for Mental Health Research Education (R25)
(PAR-17-080)
National Institute of Mental Health
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIMH Research Education Programs for Psychiatry Residents (R25)
(PAR-17-081)
National Institute of Mental Health
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
NIMH Short Courses for Mental Health-Related Research Education (R25)
(PAR-17-082)
National Institute of Mental Health
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50)

(PAR-17-168)
National Institute of Mental Health
Application Receipt/Submission Dates: May 24, 2018; May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34)
(PAR-16-113)
National Institute of General Medical Sciences
Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization
Research Initiative for Scientific Enhancement (RISE) (R25)
(PAR-16-118)
National Institute of General Medical Sciences
Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization
Research Initiative for Scientific Enhancement (RISE) (R25)
(PAR-16-361)
National Institute of General Medical Sciences
Application Receipt/Submission Date: May 25, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates

NICHD Research Education Programs (R25)

(PAR-17-183)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Dates: May 25, 2018; May 25, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32)

(PAR-17-096)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute on Drug Abuse
National Institute of General Medical Sciences
National Institute of Mental Health
Application Receipt/Submission Dates: May 25, 2018; May 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)

(PAR-17-249)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30)

(PAR-17-208)
National Institute of General Medical Sciences
Application Receipt/Submission Dates: May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Team-Based Design in Biomedical Engineering Education (R25)
(PAR-16-108)
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date: May 31, 2018, by 5:00 PM local time of applicant organization
Silvio O. Conte Digestive Diseases Research Core Centers (P30)
(RFA-DK-17-001)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date: June 1, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01)
(PAR-16-114)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date: June 5, 2018, by 5:00 PM local time of applicant organization
Methods for Prevention Packages Program IV (MP3 IV) (R01)
(PAR-16-124)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt/Submission Date: June 7, 2018, by 5:00 PM local time of applicant organization
Surgical Disparities Research (R01)
(PAR-16-391)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Office of Research on Women's Health
Application Receipt/Submission Dates: June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Exploratory/Developmental Surgical Disparities Research (R21)
(PAR-16-392)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Office of Research on Women's Health
Application Receipt/Submission Dates: June 7, 2018 and June 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03)
(PAR-15-343)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date: September 07, 2018 
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)
(PAR-16-139)
National Cancer Institute
Application Receipt/Submission Date: September 07, 2018
Natural History Studies for Rare Disease Product Development: Orphan Products Research Project Grant (R01)
(RFA-FD-16-043)
Food and Drug Administration
Application Receipt Date: October 15, 2018, by 11:59 PM Eastern Time
BD2K Support for Meetings of Data Science Related Organizations (U13)
(RFA-CA-16-020)
National Cancer Institute
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of Behavioral and Social Science Research
Office of Research on Women's Health
The Common Fund/Office of Strategic Coordination
Application Receipt Dates: November 31, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Education and Health: New Frontiers (R21)
(PAR-16-078)
Office of Behavioral and Social Science Research
National Cancer Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Application Receipt/Submission Date: January 07, 2019
Education and Health: New Frontiers (R03)
(PAR-16-079)
Office of Behavioral and Social Science Research
National Cancer Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Application Receipt/Submission Date: January 07, 2019
Education and Health: New Frontiers (R01)
(PAR-16-080)
Office of Behavioral and Social Science Research
National Cancer Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Application Receipt/Submission Date: January 07, 2019
Core Centers for Clinical Research (CCCR) (P30)
(RFA-AR-17-002)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date: January 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates